机器人辅助卒中患者平衡与步态康复(ROAR-S):一项初步随机对照试验的研究方案
这是一项在意大利罗马招募24例卒中患者的干预性、单盲、初步随机对照试验,计划于2022年1月至12月开展。试验组在常规治疗基础上接受Hunova®机器人平台平衡康复,每周3次、共4周(12次)、每次45分钟;对照组仅接受常规治疗。目的是评估联合机器人平衡治疗对平衡、疲劳、生活质量及运动认知表现的改善效果。
要点
- 研究纳入24例卒中患者,随机分为Hunova®机器人平衡康复联合常规治疗组与单纯常规治疗组。
- 试验组每周3次、共4周(12次)、每次45分钟机器人平衡训练。
- 主要评估平衡、疲劳、生活质量及运动认知表现,治疗前后各评估一次。
核心结论
- 研究旨在评估常规治疗联合Hunova®机器人平衡治疗相比单纯常规治疗对平衡、疲劳、生活质量及运动认知表现的改善作用。
- 作者认为机器人评估有助于识别最合适和个体化的康复治疗,可能减少虚弱人群的残疾并改善生活质量。
研究设计与样本
- 干预性、单盲、初步随机对照试验,计划招募24例男女卒中患者。
- 研究在罗马Fondazione Policlinico Universitario A. Gemelli IRCCS的UOC康复与物理医学部门于2022年1月至12月进行招募、评估和治疗。
主要发现
- 原文为研究方案,未报告试验结果。
关键数值与推荐
- 试验组使用Hunova®机器人平台(Movendo Technology srl,热那亚,意大利)进行平衡障碍专项康复,每周3次、共4周(12次)、每次45分钟,并联合常规治疗。
- 对照组仅按日常流程接受常规治疗。
- 所有患者在4周治疗开始和结束时接受临床和仪器评估。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Stroke, the incidence of which increases with age, has a negative impact on motor and cognitive performance, quality of life, and the independence of the person and his or her family, leading to a number of direct and indirect costs. Motor recovery is essential, especially in elderly patients, to enable the patient to be independent in activities of daily living and to prevent falls. Several studies have shown how robotic training associated with physical therapy influenced functional and motor outcomes of walking after stroke by improving endurance and walking strategies. Considering data from previous studies and patients' needs in gait and balance control, we hypothesized that robot-assisted balance treatment associated with physical therapy may be more effective than usual therapy performed by a physical therapist in terms of improving static, dynamic balance and gait, on fatigue and cognitive performance. METHODS: This is an interventional, single-blinded, preliminary randomized control trial. Twenty-four patients of both sexes will be recruited, evaluated, and treated at the UOC Rehabilitation and Physical Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS in Rome from January to December 2022. Patients will be randomized into two groups: the experimental group will perform specific rehabilitation for balance disorder using the Hunova® robotic platform (Movendo Technology srl, Genoa, IT) for 3 times a week, for 4 weeks (12 total sessions), and for 45 min of treatment, in addition to conventional treatment, while the conventional group (GC) will perform only conventional treatment as per daily routine. All patients will undergo clinical and instrumental evaluation at the beginning and end of the 4 weeks of treatment. CONCLUSIONS: The study aims to evaluate the improvement in balance, fatigue, quality of life, and motor and cognitive performance after combined conventional and robotic balance treatment with Hunova® (Movendo Technology srl, Genoa, IT) compared with conventional therapy alone. Robotic assessment to identify the most appropriate and individualized rehabilitation treatment may allow reducing disability and improving quality of life in the frail population. This would reduce direct and indirect social costs of care and treatment for the National Health Service and caregivers. TRIAL REGISTRATION: ClinicalTrials.gov NCT05280587. Registered on March 15, 2022.
引用
- Giovannini S, Iacovelli C, Brau F, et al. RObotic-Assisted Rehabilitation for balance and gait in Stroke patients (ROAR-S): study protocol for a preliminary randomized controlled trial. Trials. 2022. PMID: 36224575. doi:10.1186/s13063-022-06812-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。